Diphenhydramine Research Articles

Gamma irradiation effects on diphenhydramine hydrochloride: an EPR study

This study seeks to detect and characterize the free radicals generated in gamma-irradiated diphenhydramine hydrochloride (DP-HCl), a precursor for an antihistamine drug. The investigation aims to assess the radiation sensitivity of DP-HCl under varying microwave power, radiation doses, temperature conditions, and storage durations. After irradiation with 14 kGy, the observed radical associated with the –ĊHCH2N– fragment exhibited a singlet signal with a g-value of g = 2.0016 ± 0.0005. The signal intensities from experimental spectra within the 2–20 kGy dose range were found to exhibit the optimal fit with a polynomial function. Experimental spectra were recorded in the temperature range of 123–423 K to investigate whether distinct types of radicals were formed at low and high temperatures. Furthermore, the stability of the free radicals generated in the irradiated sample was assessed by determining the extinction curves of the signal intensities of the sample. The novelty of this study lies in examining the radiation sensitivity of the –ĊHCH2N– radical, demonstrating its remarkable stability across different temperatures and storage durations. This leads to the conclusion that radiation sterilization of the DP-HCl sample is not suitable.

Effects of diphenhydramine on crayfish cytochrome P450 activity and antioxidant defence mechanisms: First evidence of CYP2C- and CYP3A-like activity in marbled crayfish

Growing evidence has reported that diphenhydramine (DPH), an ionisable antihistamine, is widely present in surface waters across the world. Relative to vertebrates studied, its impact on invertebrates, particularly concerning cytochrome P450 (CYP) metabolism and oxidative stress, remains poorly understood. In this study, we aimed to investigate the effects of 2, 20, and 200 µg/L DPH on marbled crayfish (Procambarus virginalis) after 96-h exposure. Specifically, we assessed CYP activity, antioxidant enzyme responses, and acetylcholinesterase (AChE) activity in gills, muscle, and hepatopancreas. The crayfish CYP metabolised fluorogenic CYP-metabolic substrates of 7-benzyloxy-4-trifluoromethylcoumarin (BFC) and dibenzylfluorescein (DBF), which evidenced the activity of CYP2C and CYP3A isoforms, well known in mammalian detoxification metabolism. Both BFC and DBF dealkylations showed a positive correlation with each other but were negatively correlated to water and haemolymph DPH concentrations. Exposure to 200 µg/L DPH elicited an apparent inhibition trend, albeit not significant, in BFC- and DBF-transformation activities in crayfish. Other tested 7-benzyloxyresorufin and 7-pentoxyresorufin substrates were poorly metabolised, suggesting their relatively low activity or the lack of mammalian-like CYP1A and CYP2B isoforms in marbled crayfish. The significant modulation of antioxidant enzymes was demonstrated in gills and hepatopancreas. The exposure to DPH did not alter the activity of AChE. Integrated biomarker response version 2 showed the highest cumulative effect of DPH exposure on gills, implying that gill tissue is the most reliable matrix for evaluating DPH toxicity. Activities of glutathione peroxidase and glutathione-S-transferase were the most deviated determinants among the investigated biomarkers, providing insights into the DPH toxicity in crayfish. This study brought the first insight into utilising the fluorogenically active substrates BFC and DBF to demonstrate the CYP involvement in the detoxification metabolism in marbled crayfish. Further, our results provided information on valuable antioxidant defence mechanisms and biomarker responses for a future DPH toxicity assessment in aquatic organisms.

Enhanced mineralization of pharmaceutical residues at circumneutral pH by heterogeneous electro-Fenton-like process with Cu/C catalyst

Conventional electro-Fenton (EF) process at acidic pH ∼3 is recognized as a highly effective strategy to degrade organic pollutants; however, homogeneous metal catalysts cannot be employed in more alkaline media. To overcome this limitation, pyrolytic derivatives from metal-organic frameworks (MOFs) have emerged as promising heterogeneous catalysts. Cu-based MOFs were prepared using trimesic acid as the organic ligand and different pyrolysis conditions, yielding a set of nano-Cu/C catalysts that were analyzed by conventional methods. Among them, XPS revealed the surface of the Cu/C-A2-Ar/H2 catalyst was slightly oxidized to Cu(I) and, combined with XRD and HRTEM data, it can be concluded that the catalyst presents a core-shell structure where metallic copper is embedded in a carbon layer. The antihistamine diphenhydramine (DPH), spiked into either synthetic Na2SO4 solutions or actual urban wastewater, was treated in an undivided electrolytic cell equipped with a DSA-Cl2 anode and a commercial air-diffusion cathode able to electrogenerate H2O2. Using Cu/C as suspended catalyst, DPH was completely degraded in both media at pH 6–8, outperforming the EF process with Fe2+ catalyst at pH 3 in terms of degradation rate and mineralization degree thanks to the absence of refractory Fe(III)-carboxylate complexes that typically decelerate the TOC abatement. From the by-products detected by GC/MS, a reaction sequence for DPH mineralization is proposed.

Thermal and Cardiovascular Responses during Exertional Heat Stress after Diphenhydramine Use: A Randomized Crossover Trial.

Despite sparse systematic evidence, current exercise heat safety recommendations suggest that antihistamines blunt sweating and increase the risk for heat-related injury during exertional heat stress. The primary purpose of the present study was to examine whether diphenhydramine hydrochloride (DPH), a first-generation antihistamine, effects the sweating, core temperature, and heart rate response during exertional heat stress using a double-blind randomized crossover design. On two occasions separated by >48 h, 20 healthy adults (10 females, 23 ± 3 y, BSA: 1.9 ± 0.2 m2, BMI: 23.7 ± 2.2 kg·m-2) orally consumed either 50 mg of DPH or placebo (PLA), and then rested for 2 h in a climate-controlled room maintained at 30 °C and 35%RH (Heat Index of ~29 °C), followed by a 60-minute fixed-heat production treadmill walk (6.3 ± 1.0 W·kg-1). Whole-body sweat loss (WBSL), local sweat rate (LSR), rectal temperature (Trec), and heart rate (HR) were measured. WBSL was not different between conditions (PLA: 406 ± 78 g; DPH: 396 ± 75 g, P = 0.26, treatment effect: -10 g 95%CI [-28, 8]). No differences were observed for the onset for sweating (PLA: 13.5 ± 2.4 min; DPH: 13.3 ± 2.7 mins, P = 0.79), and steady-state LSR (PLA: 0.83 ± 0.26 mg·cm-2·min-1; DPH: 0.82 ± 0.27 mg·cm-2·min-1, P = 0.99). No difference in baseline Trec was observed (PLA: 37.09 ± 0.35 °C, DPH: 37.13 ± 0.33 °C, P = 0.68), and the 60-min ΔTrec was not different (P = 0.99) between PLA (0.83 ± 0.29 °C) and DPH (0.81 ± 0.30 °C). HR was similar at baseline (PLA: 86 ± 13 BPM, DPH: 84 ± 11 BPM, P = 0.30) and end-exercise (PLA: 134 ± 28 BPM, DPH: 132 ± 26BPM, P = 0.90). 50 mg of DPH does not modify the sweating, core temperature, and heart rate response during exertional heat stress in young healthy adults.

Factors Associated With the Use of Over-the-Counter Sleep Aids Among Jazan University Students.

Sleep aids, classified by their mechanisms of action, can promote sleep but may be misused, leading to harm. Exercise and pharmacological interventions like antihistamines, melatonin, and benzodiazepines also help manage sleep disorders. In Saudi Arabia, sleep disorders are prevalent, especially among university students. Our study examines the prevalence and usage of the medication containing diphenhydramine hydrochloride, among Jazan University students, aiming to inform better practices and highlight related risks and benefits. A cross-sectional design study was conducted among Jazan University students in Saudi Arabia. The sampling of data utilized random selection. Data was cleaned in Excel and analyzed using IBMSPSSStatistics for Windows, Version 29 (Released 2023; IBM Corp., Armonk, New York, United States). Our study comprised 437 participants from Jazan University aged 18-25 years. The majority reported earning less than 5000 SAR monthly and were unmarried (91.8%). Remarkably, 13.7% of participants were diagnosed with insomnia. Sleep aid containing diphenhydramine hydrochloride, utilized for mild to moderate pain relief and sleep induction, was the most prevalent medication, with 56.3% of participants having used itand 9.4% using it continuously for over 10 nights. Significant predictors for usage of sleep aids containing diphenhydramine hydrochloride included gender (p=0.041), with male students exhibiting higher usage rates, and college type (p<0.001), particularly medical students. Multivariate analysis confirmed male gender and enrollment in medical colleges as robust predictors. Age, income, marital status, and employment variables showed no significant associations. Our study highlights a considerable prevalence ofsleep aids containing diphenhydramine hydrochloride usage among Jazan University students, notably influenced by gender and college type. Male gender and enrollment in medical colleges emerged as significant predictors of their usage.

Oral lichenoid drug eruption due to osimertinib for lung cancer.

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR) are linked with side effects involving skin and mucosa. Herein, we present a unique case of oral lichenoid drug eruption (LDE) in a patient treated with osimertinib. A 75-year-old woman was diagnosed with metastatic EGFR-mutated lung adenocarcinoma, and started on osimertinib 80 mg PO daily. At 24 months of therapy, the patient developed a painful, red, and white striated oral lesion involving the left buccal mucosa and the adjacent buccal aspect of gingivae. Biopsy showed oral LDE. Causality assessment between osimertinib and the oral LDE via Naranjo Adverse Drug Reaction probability scale revealed a score of 5. Osimetinib discontinuation was not felt to be in the best interest of the patient. Therefore, diphenhydramine HCL mouthwash every 6 h PRN (before meals) was started. Spicy and hot foods were discontinued. At a four-week follow-up visit, the patient reported moderate improvement in her symptoms. Oral LDEs are considered premalignant lesions as they can transform into squamous cell carcinoma; therefore, regular follow-up is needed. Awareness of this potential side effect of osimertinib would also prevent unnecessary (and potentially costly) work-up and lead to its prompt diagnosis and treatment.

Zuclopenthixol decanoate toxicity in an 8‐month‐old colt causing extrapyramidal neurological signs

SummaryZuclopenthixol decanoate is a dopamine antagonist licensed for human use to manage schizophrenia and paranoid psychosis. It is in the same drug class (thioxanthene) as fluphenazine decanoate, a drug whose use in horses is reported anecdotally for providing long‐acting sedation. This case study describes severe extrapyramidal signs seen in a Thoroughbred colt after zuclopenthixol decanoate administration. The colt was presented to a referral hospital for an unusual manifestation of colic signs. On admission, the colt began to show clear extrapyramidal neurological signs. The initial suspicion was of fluphenazine decanoate toxicity, which in the limited published literature is treated with intravenous formulations of diphenhydramine hydrochloride and benztropine mesylate. At the time of writing both were unavailable in the United Kingdom without an import license. The closest alternative option, oral diphenhydramine was administered alongside intravenous atropine and pergolide. Improvements in the colt's demeanour and neurological status was noted within 24 h. The colt was hospitalised for a total of 26 days and at time of discharge was clinically normal. Follow‐up communication 3 months after discharge confirmed that the colt had remained neurologically normal. Crucially, toxicology testing submitted to Cornell University was negative for common toxins, including fluphenazine decanoate. Specific secondary testing was performed after suspicion the administration of zuclopenthixol decanoate was raised, which was positive for this compound. Routine drug testing would, therefore, not identify the use of this behaviour modifying drug. Clinical data regarding the use of zuclopenthixol in animals is limited to its use in the translocation of wildlife to relieve stress and aid acclimatisation. To our knowledge, there is no available literature describing the administration of zuclopenthixol decanoate in equine patients.

Screening 800 putative endocrine disrupting chemicals in a representative mammal, bird, and fish using a neurochemical cell-free testing platform

There is global demand for novel ecotoxicity testing tools that are based on alternative to animal models, have high throughput potential, and may be applicable to a wide diversity of taxa. Here we scaled up a microplate-based cell-free neurochemical testing platform to screen 800 putative endocrine disrupting chemicals from the U.S. Environmental Protection Agency's ToxCast e1k library against the glutamate (NMDA), muscarinic acetylcholine (mACh), and dopamine (D2) receptors. Each assay was tested in cellular membranes isolated from brain tissues from a representative bird (zebra finch = Taeniopygia castanotis), mammal (mink = Neogale vison), and fish (rainbow trout = Oncorhynchus mykiss). The primary objective of this short communication was to make the results database accessible, while also summarising key attributes of assay performance and presenting some initial observations. In total, 7200 species-chemical-assay combinations were tested, of which 453 combinations were classified as a hit (radioligand binding changed by at least 3 standard deviations). There were some differences across species, and most hits were found for the D2 and NMDA receptors. The most active chemical was C.I. Solvent Yellow 14 followed by Diphenhydramine hydrochloride, Gentian Violet, SR271425, and Zamifenacin. Nine chemicals were tested across multiple plates with a mean relative standard deviation of the specific radioligand binding data being 24.6%. The results demonstrate that cell-free assays may serve as screening tools for large chemical libraries especially for ecological species not easily studied using traditional methods.

Desloratadine ameliorates paclitaxel-induced peripheral neuropathy and hypersensitivity reactions in mice.

Paclitaxel (PTX) serves as a primary chemotherapy agent against diverse solid tumors including breast cancer, lung cancer, head and neck cancer and ovarian cancer, having severe adverse effects including PTX-induced peripheral neuropathy (PIPN) and hypersensitivity reactions (HSR). A recommended anti-allergic agent diphenhydramine (DIP) has been used to alleviate PTX-induced HSR. Desloratadine (DLT) is a third generation of histamine H1 receptor antagonist, but also acted as a selective antagonist of 5HTR2A. In this study we investigated whether DLT ameliorated PIPN-like symptoms in mice and the underlying mechanisms. PIPN was induced in male mice by injection of PTX (4 mg/kg, i.p.) every other day for 4 times. The mice exhibited 50% reduction in mechanical threshold, paw thermal response latency and paw cold response latency compared with control mice. PIPN mice were treated with DLT (10, 20 mg/kg, i.p.) 30 min before each PTX administration in the phase of establishing PIPN mice model and then administered daily for 4 weeks after the model wasestablished. We showed that DLT administration dose-dependently elevated the mechanical, thermal and cold pain thresholds in PIPN mice, whereas administration of DIP (10 mg/kg, i.p.) had no ameliorative effects on PIPN-like symptoms. We found that the expression of 5HTR2A was selectively elevated in the activated spinal astrocytes of PIPN mice. Spinal cord-specific 5HTR2A knockdown by intrathecal injection of AAV9-5Htr2a-shRNA significantly alleviated the mechanical hyperalgesia, thermal and cold hypersensitivity in PIPN mice, while administration of DLT (20 mg/kg) did not further ameliorate PIPN-like symptoms. We demonstrated that DLT administration alleviated dorsal root ganglion neuronal damage and suppressed sciatic nerve destruction, spinal neuron apoptosis and neuroinflammation in the spinal cord of PIPN mice. Furthermore, we revealed that DLT administration suppressed astrocytic neuroinflammation via the 5HTR2A/c-Fos/NLRP3 pathway and blocked astrocyte-neuron crosstalk by targeting 5HTR2A. We conclude that spinal 5HTR2A inhibition holds promise as a therapeutic approach for PIPN and we emphasize the potential of DLT as a dual-functional agent in ameliorating PTX-induced both PIPN and HSR in chemotherapy. In summary, we determined that spinal 5HTR2A was selectively activated in PIPN mice and DLT could ameliorate the PTX-induced both PIPN- and HSR-like pathologies in mice. DLT alleviated the damages of DRG neurons and sciatic nerves, while restrained spinal neuronal apoptosis and CGRP release in PIPN mice. The underlying mechanisms were intensively investigated by assay against the PIPN mice with 5HTR2A-specific knockdown in the spinal cord by injection of adeno-associated virus 9 (AAV9)-5Htr2a-shRNA. DLT inhibited astrocytic NLRP3 inflammasome activation-mediated spinal neuronal damage through 5HTR2A/c-FOS pathway. Our findings have supported that spinal 5HTR2A inhibition shows promise as a therapeutic strategy for PIPN and highlighted the potential advantage of DLT as a dual-functional agent in preventing against PTX-induced both PIPN and HSR effects in anticancer chemotherapy.

Does diphenhydramine exert a sex-dependent effect on sudomotor responses during exertional heat stress?

Introduction: The first-generation H1 antihistamine diphenhydramine hydrochloride (DPH) is a potent antimuscarinic agent which may compromise sweat output during heat stress. DPH consumption prior to exertional heat stress could further suppress the sweating response in females due to their lower postjunctional cholinergic sensitivity of the sweat glands relative to males. Objective and Hypothesis: The purpose of the present study was to test the hypothesis that DPH would reduce sweating to a greater extent in females relative to males due to differences in cholinergic sensitivity at the sweat gland. Methods: Equal groups (10 per group) of males (24±3 y; 82.6±10.1 kg; 182±5 cm) and females (22±3 y, 67.7±7.8 kg, 171±6 cm) completed two experimental trials presented in a randomized double-blind fashion. Upon arrival to lab, participants consumed either i) a placebo (PLA) pill or ii) 50 mg DPH and then rested in a room maintained at ~29.5°C &amp; 35% RH for 2 hours before conducting a 60-minute treadmill march at a fixed rate of heat production relative to body surface area (~245 W/m2). Rectal temperature (Trec), local sweat rate of the forearm (LSR), and whole body sweat loss (WBSL) were measured. Sex-segregated analysis was conducted for each outcome variable as the difference between PLA and DPH. Results: Baseline Trec did not differ within sex between PLA and DPH (males: -0.10±0.26°C; females: -0.05±0.33°C, P=0.70), however a higher absolute baseline Trec was observed in females compared to males (P=0.006). In comparison to PLA, DPH did not exert a sex-dependent effect on ΔTrec following 60-min of exercise (males: 0.04±0.11°C; females: 0.02±0.37°C, P=0.90). No sex-dependent effect on the onset of sweating was observed between DPH and PLA (males: -0.4±2.6 min; females: 0.6±2.4 min, P=0.34). DPH did not exert a sex-dependent effect on LSR at steady-state (males: 0.03±0.25 mg/cm2/min; females: -0.01±0.21 mg/cm2/min, P=0.71). Lastly, no sex-dependent effect on WBSL was observed between PLA and DPH (males: 14±34 g; females: 6±43 g, P=0.98). Conclusion: Current evidence suggests that sex does not independently modulate the sweating response during exertional heat stress following the consumption of 50 mg of DPH. This research is supported by Dr. Ravanelli’s Research Seed Grant from the Centre for Research in Occupational Safety &amp; Health, and Dr. Ravanelli’s Natural Sciences and Engineering Research Council of Canada Discovery Grant (PIN#2022-05096). This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Green Electrochemical Sensing: Novel Ion-Selective Electrode Method for Precise Determination of Dimenhydrinate and its Metabolite along with Cinnarizine in Pharmaceutical and Plasma Samples

Green and sustainable scientific research is crucial for health and environmental improvement. Electrochemical analysis simplifies complex processes, saving time and cost. Ion selective electrode method, a key in green analytical chemistry, was utilized. A highly selective solid contact sensor was developed for two applications, detecting cinnarizine (CIN) and dimenhydrinate (DMH) in pharmaceuticals, and identifying CIN and diphenhydramine (DIP) in human plasma. Careful selection of ionophores ensured accurate detection. Multi-wall carbon-nanotubes (MWCNTs) facilitate rapid and precise measurement. The concentration range for CIN, DMH, and DIP was 1 × 10−6 M to 1 × 10−2 M, with mean recovery% of 100.07 ± 0.80, 100.12 ± 0.76, and 100.07 ± 0.53, respectively. Validation parameters exhibited accuracy and precision, with accuracy results of 100.87 ± 0.89, 99.96 ± 0.42, and 99.82 ± 0.31, and LODs of 0.5 × 10−6, 1.0 × 10−7, and 0.2 × 10−6 for CIN, DMH, and DIP, respectively. The study highlighted benefits like speed, economy, and sustainability, emphasizing the electrode’s reusability. SWOT analysis and environmental assessments further underscored its advantages, promising applications in pharmaceutical analysis and quality control.

Effects of diphenhydramine exposure on reproduction of mature Japanese medaka (Oryzias latipes)

Diphenhydramine (DPH) is an antihistamine drug. It has been frequently detected in the environment, because it is not completely degraded in wastewater treatment plants. Recent studies have shown the adverse effects of DPH exposure to various aquatic organisms; however, its chronic effects on fish have been poorly elucidated. In this study, several pairs of mature Japanese medaka (Oryzias latipes) were exposed to DPH for a long period to determine the effects of DPH exposure on the subsequent generations, number of spawned and fertilized eggs, expression of sex-related genes, feeding behavior, embryo development, hatching rate, malformations among the hatched larvae, and mortality rate. The number of spawned eggs significantly decreased, when the parent fish were continuously exposed to 31.6 μg/L DPH for over 46 days. DPH exposure also altered the feeding behavior of medaka individuals, and increased the larval mortality rate. The effects of DPH exposure to fish may occur to some extent in the actual aquatic environment, although the risk evaluations in the field are limited.

Influence the diphenhydramine hydrochloride–sodium carboxymethyl cellulose complex for nanoaggregate formation

This study aimed to create nanoaggregates that improve the synergistic interaction between the opposing charges in drug-polyelectrolyte complexes. In this study, sodium carboxymethyl cellulose (NaCMC) polyelectrolytes and diphenhydramine hydrochloride (DPC) drug molecules were used to form the nanoaggregate. The aggregation behaviour of NaCMC-DPC complexes was determined by using conductivity methods. The critical micelle concentrations (CMC) of NaCMC were reduced from 0.737 to 0.337 g/l in the aqueous and 29.18 mg/l in the DPC. The modified Corrin and Harkins (CH) and Frahm's approaches evaluated the binding efficiency of the NaCMC-DPC interaction. NaCMC-DPC complexes were examined by transmission electron microscopy (TEM) and dynamic light scattering (DLS) techniques to conform to the formation of bilayer vesicles. Furthermore, we prepared the silver nanoparticles by using NaCMC-DPC complex mixtures. We demonstrated how NaCMC-DPC mixtures might influence the self-assembly of silver nanochain designs that differed from open "end-to-end" networks. The results indicated that the assembly of silver nanochains was regulated by a variation of electrostatic interactions inside the NaCMC-DPC components, which organized themselves around anisotropic nanochains surfaces. Among the optical properties altered by the linear assembly, the longitudinal surface plasmon resonance band at 624 nm has an enhanced redshift.

TREATMENT OF SCABIOSIS AND TOXOCARIOSIS IN DOMESTIC CAT

Skin and digestive diseases are the most common problems encountered in cats. A six-month-old domestic cat with a body weight of 1.42 kg experienced problems with the skin and digestive system at the same time. Cases of cats complain that they often scratch and excrete worms when defecating, the feces are yellow and have a paste-like consistency. This research aims to determine the disease agent and intensity of infection that attacks cats so that appropriate treatment can be provided. On physical examination, alopecia, hyperkeratosis, crusting and scales were found on the head, bilateral ears, neck and elbow area. Supporting examinations carried out were skin examination using skin scraping, trichogram, cytological examination using the tape acetate method and otic swab with diffquick staining as well as fecal examination using the floating method and counting worm eggs using the Mc Master method. The diagnosis is confirmed based on the history, physical examination, and examination with results of scabiosis and toxocaryosis. The causative therapy used in this case was ivermectin (Ivomec®) injection at a dose of 300μg/kg BW subcutaneously given three times on days 0, 7 and 14 and pyrantel pamoate (Combantrin®) therapy at a dose of 25 mg/kg BW orally. Symptomatic therapy uses intramuscular injection of diphenhydramine HCl (2 mg/kg BW) and (chlorpeniramine maleate®) at a dose of 2 mg/head given 2x¼ orally given for three days, followed by supportive therapy given multivitamins and minerals (Caviplex®) given once a day orally for seven days. Topical therapy is given with sulfur soap to bathe cats at least once a week. The cat showed good progress starting from the third day, the level of pruritus decreased, then on the fourth day the cat did not expel worms from the anus and the stomach did not look as enlarged as when it was first examined, and on the sixth day it started to show hair growth, alopecia, crusting and hyperkeratosis began to decrease. After administering ivermectin the second time, the cat's case began to improve with the level of pruritus decreasing and the hair slowly growing. After the third injection, namely on the fourteenth day, the cat named Bolu was returned to its owner with improved skin condition and no longer scratching. Based on the history, physical examination and laboratory examination, the cat was given therapy by administering antihistamines, antiparasitics, worm medicine, as well as support by administering vitamins and topical use of sulfur soap. It is important for cat owners to consistently bathe their cats and give them regular deworming medication to prevent recurrent infections.

A Rapid Continuous Flow Injection Analysis Method Development for Diphenhydramine Hydrochloride

Background: Diphenhydramine hydrochloride (DPH) is widely used as an antihistamine for treating various allergic conditions and symptoms. Traditional analytical methods for quantifying DPH often involve complex procedures and instrumentation. However, recent advancements in nanotechnology and analytical techniques offer opportunities for developing simpler and more efficient methods for DPH analysis. Method: This study presents a novel approach for quantifying DPH using continuous flow injection analysis (CFIA) combined with turbidimetric measurements. The precipitation reaction between DPH and 3,5-dinitro salicylic acid was utilized in an aqueous medium system. Various physical and chemical parameters were optimized, including the concentration of precipitating reagent, reaction medium (acids and salts), irradiation source intensity, volume of sample segment, and delay reaction coil. Results: Optimization of physical and chemical parameters revealed that a concentration of 15 m.mol/Liter for 3,5-dinitro salicylic acid, distilled water as the reaction medium, and an irradiation source intensity of 3.1 VDC produced optimal results. The linear dynamic range for DPH concentration was determined to be 0.01-20 m.mol/Liter. Comparison with the traditional UV-spectrophotometric method showed comparable results, indicating the reliability of the proposed CFIA method. Conclusion: The CFIA method presented in this study offers several advantages over traditional analytical methods for quantifying DPH in pharmaceutical formulations. It provides high sensitivity, speed, simplicity, and improved accuracy. The proposed approach has the potential for widespread application in pharmaceutical analysis, offering a cost-effective and easily manipulable solution for routine laboratory use. Overall, this study demonstrates a significant advancement in the measurement of DPH, which could simplify processes for pharmaceutical analysis and enhance industrial production levels.

Determination of chromatographic conditions for quantitative assessment of active components in complex nasal spray after manufacturing and expiry date

The aim of the work is the development of chromatographic conditions, the study of the validation characteristics of the method of quantitative determination of phenylephrine hydrochloride, nitrofural, lidocaine hydrochloride and diphenhydramine hydrochloride, panthenol, povidone in the joint presence in the nasal spray by a complex method of liquid chromatography with UV detection. Evaluation of the quantitative content of active components after manufacturing and during the shelf life.&#x0D; Materials and methods. Agilent 1260 liquid chromatographs, equipped with a diode-matrix detector from the company "Agilent technologies", USA. Chromatographic columns 250×4.6 mm in size, filled with octadecylsilyl silica gel for chromatography (Zorbax StableBond SB-Aq, Agilent company), mobile phase A - phosphate buffer solution pH 7.0 - acetonitrile P (1650:350), mobile phase B – acetonitrile P; elution mode – gradient; mobile phase flow rate – 1.0 ml/min; detection wavelengths – 220 nm (for panthenol, phenylephrine, povidone, diphenhydramine) and 235 nm (for nitrofural and lidocaine).&#x0D; Results. Chromatographic separation conditions were developed for the co-presence determination of six target substances: panthenol, phenylephrine hydrochloride, nitrofural, povidone, lidocaine hydrochloride and diphenhydramine hydrochloride. The suitability of the technique for this task was confirmed by determining the validation characteristics. The methodology at the appropriate level is characterized by specificity, linearity, correctness and convergence in the range of application for panthenol (range 20.33-38.26 mg/ml, ΔZ=0.93 ≤ max ΔZ=3.20, a=0.63 max a=5.12, r = 0.9978 min r= 0.9924), phenylephrine hydrochloride (range 1,70-3,21 mg/ml, ΔZ=0.51 ≤ max ΔZ=3.20, a=0.15 max a=5.12, r = 0.9984 min r= 0.9924), nitrofural (range 0.137-0.257 mg/ml, ΔZ=0.91 ≤ max ΔZ=3.20, a=0.032 max a=5.12, r = 0.9987 min r= 0.9924) povidone (range 20,44-38,50 mg/ml, ΔZ=0.23 ≤ max ΔZ=3.20, a=2,33 max a=5.12, r = 0.9942 min r= 0.9924), lidocaine hydrochloride (range 6,80-12,81 mg/ml, ΔZ=0.34 ≤ max ΔZ=3.20, a=0.66 max a=5.12, r = 0.9988 min r= 0.9924), diphenhydramine hydrochloride (range 1,36-2,56 mg/ml, ΔZ=0.20 ≤ max ΔZ=3.20, a=0.15 max a=5.12, r = 0.9980 min r= 0.9924). There are no significant changes when stored at 25 °C for 6 months.&#x0D; Conclusions. An analytical method of quantitative determination of the component composition in an extemporaneous nasal spray by a complex method of high-performance liquid chromatography has been developed. The determined validation parameters confirm the correctness of the methodology. The chemical stability of the dosage form is observed for 6 months

Surface activity and micellization of streptomycin sulfate and diphenhydramine hydrochloride in the presence of alkali and alkaline earth metal chlorides

ABSTRACT The study investigated the surface tension of the surface-active drugs streptomycin sulfate and diphenhydramine hydrochloride using three uni-univalent and three bi-univalent electrolytes: NaCl, KCl, and RbCl (0.01 mol.kg−1), and MgCl2, CaCl2, and SrCl2 (0.002 mol.kg−1) over a temperature range of 298.15 to 313.15 K. Surface tension determination has proven instrumental in examining the micellization and surface-active properties of these drugs in the presence of specific electrolytes. The surface tension values of these drugs exhibit a decrease in magnitude with increasing drug concentration, particularly noticeable in streptomycin sulfate. This phenomenon can be elucidated by considering the delicate balance between hydrophobic and hydrophilic forces within the system. Additionally, the impact of the nature of metal halides and temperature on surface tension magnitude has been scrutinised, with interpretations focused on alterations in size. From surface tension values, the interfacial parameters, such as Γ max , A min , and π CMC were examined. The results indicate a strong affinity between drug-electrolyte molecules that reduces the surface tension values. The CMC relations govern the hydrophobic and hydrophilic interactions in the ternary system of water-drug-electrolyte. The thermodynamics of micellization explains the work done for micellization and illuminates the surface and bulk properties of drugs.

Case report: Demodicosis in a Chow-chow dog at Yours Veterinary Clinic in Padang Panjang City

Demodecosis, also known as Red Mange, Acarus Mange, and Follicular Mange, is a skin disease caused by the mite Demodex canis. Demodecosis infection can occur in dogs of all ages. This study aims to diagnose and treat the infection of Demodex sp in chow-chow dogs. Clinical signs include generalized alopecia, scales, and crusts found on the body's surface, followed by dehydration symptoms, poor skin turgor, and long CRT. Supporting examinations to determine demodecosis infection are carried out using the deep skin scrapping test method. Next, a hematological exam was carried out. The hematology examination interpreted the blood analysis results to indicate that the dog had normochromic microcytic anemia. A decrease in RBC, hemoglobin, and hematocrit indicates anemia. A low MCV indicates Microcytic, and normochromic is due to a normal MCHC. Treatment is carried out by administering ivermectin, diphenhydramine HCl, and longamox.

PNEUMONIA AND DEMODICOSIS IN CROSSBREED POMERANIAN

A Pomeranian breeddog named Beb aged 1,5 years with a body weight of 3,4 kg, experiencing respiratory problems namely coughing and yellowish nasal discharge, as well as skin problems with complaints of nausea. The purpose of this case report article is to determine the cause of the cough and skin disease that occurred in the case dog and the effectiveness of the treatment performed. During physical examination, there was a cough with moderate intensity, at the end of the cough the animal seemed to be trying to expel something from its throat. The skin showed alopecia, scale, crusts and hyperpigmentation. Radiographic examination showed radiopaque spots on the lungs. Nasal swab examination microscopically found neutrophils, skin scraping examination microscopically found Demodex canis mites. Complete blood test results showed that the case dog had hypochromic macrocytic anemia, thrombocytopenia, and lymphopenia. Based on history taking, physical examination, and supporting examination, the case dog was diagnosed with pneumonia and demodecosis. The case animal was treated with amoxicillin-clavulanic acid (15mg/kg BW; orally; twice daily; for one week and ivermectin (600 µg/kg BW subcutaneously). Symptomatic therapy was given diphenhydramine HCl (1 mg/kg BW; intramuscularly), then continued with diphenhydramine HCl (3mg/kg BW; orally; twice daily). Supportive therapy given was Livron B-Plex® and fish oil orally one tablet per day. Dogs were bathed using soap with sulfur content. The results of the 2-week treatment showed no nasal discharge, no coughing, the animal no longer exhibited nausea, the morning crusts on the ear edges had disappeared, and new hair had started to grow on the neck and back of the case animal. Owners are advised to keep their dogs out of contact with other dogs to speed up the healing process. Owners are advised to improve nutrition, hygiene, grooming, and routine vaccination and deworming.

CHLAMYDIASIS ACCOMPANIED WITH SCABIOSIS AND OTITIS EXTERNA IN CATS

A 2 year old cat of local race, female, weighing 1.74 kg with clinical symptoms of yellow discharge in the eyes and itching of the ears and all over the body. The purpose of this article is to discuss the management of cases of chlamydia accompanied by otitis and scabiosis with therapy using Oxytetracycline HCL and Ivermectin. Clinical examination revealed disturbances of the ears, eyes, and skin. Investigations in the form of complete hematology and cytology smears. The results of the cat were diagnosed with chlamydiosis accompanied by scabiosis and otitis externa with a dubius-fausta prognosis. Therapy used Oxytetracycline HCL (Oxytetracycline HCL1%) antibiotic ointment by administering 2 times a day to both eyes, 1% Ivermectin injection at a dose of 0.2 mg/kg BW s.c repeated every 14 days. Injection of Diphenhydramine HCL 1 mg/kg BW i.m, then maintenance oral Chlorpheniramine maleate (4 mg/kg q12 hours) for 5 days, Vetotic ear drops 10 ml one drop 2 times a day for 5 days in both ears, Sangobion® 1 tab once a day for 5 days and bathed with sulfur soap (JF Sulfur) twice a week. Treatment with Oxytetracycline HCL and Ivermectinl gave good results. Owners are advised to provide sufficient and nutritious feed, environmental cleanliness and maintenance tools, as well as cleanliness of the cat's body need attention. Provision of preventive therapy such as deworming and vaccines to prevent infection by agents from the outside environment.